ERBB2 and neoplasm: The differences in score distributions across cohorts (Figure 2A–C) likely stem from both biological variations due to cohort differences in tumor subtypes, stages, tumor sample cell composition and ER / HER2 status, and variations arising from out-of-distribution generalization effects (e.g., different R:NR ratios across cohorts), a well-known challenge in ML modeling.